Crossmark

PEGylated liposomes enhance the pharmacokinetics, biodistribution, anticancer efficacy, and safety of Kaempferol, a phytomolecule enrolled in clinical trials

Crossref DOI link: https://doi.org/10.1038/s41598-026-51900-5

Published Online: 2026-05-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kumar, Ayana R.

Dharshini, M. Divya

Devan, Aswathy R.

Unni, Ashok R.

Sithara, M. S.

Nair, Bhagyalakshmi

Kamath, Adithya Jayaprakash

Sah, Sunil Kumar

Pavithran, K.

Sabitha, M.

Sudheesh, M. S.

Nath, Lekshmi R.
Funding

Funding for this research was provided by:

Amrita Vishwa Vidyapeetham
License Information

Text and Data Mining valid from 2026-05-07

Accepted Manuscript valid from 2026-05-07
More Information

Article History

Received: 3 February 2026

Accepted: 30 April 2026

First Online: 7 May 2026

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below